Non-Registered Executive Jang Ji-hoon Acquires 35,000 Additional Shares of Kanaph Therapeutics with 1-Year Lock-Up

Non-registered executive Jang Ji-hoon acquired 35,000 common shares of Kanaph Therapeutics on July 15, 2026 through exercise of stock purchase rights, increasing his ownership from 1.40% to 1.66%.
The acquisition prices were 1,500 KRW for 5,000 shares and 5,390 KRW for 30,000 shares, and all newly acquired shares are subject to a 1-year lock-up from the listing date.
This report reflects an insider's personal shareholding change and does not directly affect the company's capital structure or liquidity.
[AI Summary]The insider's voluntary purchase, though small, can be interpreted as a signal of management confidence. The lock-up provision limits short-term profit-taking and may contribute to stock price stability.